Shamin Rahimi

Revisiting the mechanism of hypoxic pulmonary vasoconstriction using isolated perfused/ventilated mouse lung

A. Malhotra, D. Valdez-Jasso, P. Thistlethwaite, 2020, Pulmonary circulation.

Notch Enhances Ca2+ Entry by Activating Calcium-sensing Receptors and Inhibiting Voltage-gated K+ Channels.

P. Thistlethwaite, J. Yuan, Shanshan Song, 2020, American journal of physiology. Cell physiology.

Halofuginone, a promising drug for treatment of pulmonary hypertension

D. Valdez-Jasso, P. Thistlethwaite, J. Yuan, 2021, British journal of pharmacology.

Combination Treatment by HIF-2α Antagonist and P53 Agonist Reverses Established Pulmonary Hypertension.

J. Yuan, Haiyang Tang, Chenting Zhang, 2021, British journal of pharmacology.

Established pulmonary hypertension in rats was reversed by a combination of a HIF‐2α antagonist and a p53 agonist

J. Yuan, Haiyang Tang, Chenting Zhang, 2022 .

Endothelial platelet-derived growth factor-mediated activation of smooth muscle platelet-derived growth factor receptors in pulmonary arterial hypertension

D. Valdez-Jasso, P. Thistlethwaite, J. Garcia, 2020, Pulmonary circulation.

MicroRNA-mediated Downregulation of K+ Channels in Pulmonary Arterial Hypertension.

P. Thistlethwaite, J. Yuan, A. Makino, 2019, American journal of physiology. Lung cellular and molecular physiology.

Endothelial platelet-derived growth factor-mediated activation of smooth muscle platelet-derived growth factor receptors in pulmonary arterial hypertension

D. Valdez-Jasso, P. Thistlethwaite, J. Yuan, 2020, Pulmonary circulation.